Phaeochromocytoma unearthed by fluoxetine

Postgraduate Medical Journal

Volumn 76, Issue 895, 2000, Pages 303-

  Kashyap, A S ^a  

^a ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

Fluoxetine; Phaeochromocytoma; Selective serotonin reuptake inhibitor

Indexed keywords

CATECHOLAMINE; FLUOXETINE; PAROXETINE;

ADULT; ARTICLE; CASE REPORT; CATECHOLAMINE RELEASE; DEPRESSION; HUMAN; HYPERTENSION; MALE; PHEOCHROMOCYTOMA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; FLUOXETINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHEOCHROMOCYTOMA; SEROTONIN UPTAKE INHIBITORS;

EID: 1642633586     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.76.895.303     Document Type: Article

References (6)

1. Kaufmann JS. Phaeochromocytoma and tricyclic antidepressants (letter). JAMA 1974;229:1282.
2. Montastruc JL, Chamontin B, Senard JM, et al. Pseudo-phaeochromocytoma in a parkinsonian patient treated with fluoxetine plus selegiline (letter). Lancet 1993;341: 555.
3. Magnussen I, Tonder K, Engbaek F. Paroxetine a potent selective long-acting inhibitor of synaptosomal 5-HT reuptake in mice. J Neural Trans 1982;55:217-26.
4. Sindrup SH, Brosen K, Gram LF, et al. The relationship between paroxetine and sparteine oxidation polymorphism. Clin Pharmacol Ther 1992;51:278-87.
5. Prichard BN, Smith CC. Serotonin: receptor and antagonist. Summary of symposium. Clin Physiol Biochem 1990; 8(suppl 13): 120-8.
6. Seelen M, de Meijer P, Meinders AE. Serotonin reuptake inhibitor unmasks a phaeochromocytoma. Ann Intern Med 1997;126:333.